Results 1 to 10 of about 273,684 (155)

Access to Medicines, Access to Markets [PDF]

Frontiers in Sociology, 2020
This article explores some uses by the pharmaceutical industry of language from the “access to medicines” movement in global health, sometimes for goals almost completely opposite to those of the movement.
Sergio Sismondo
doaj   +5 more sources

Access to medicines for children in China. [PDF]

BMJ Paediatr Open, 2022
Access to essential medicines for children is a big challenge, particularly in low-income and middle-income countries. In China, the average availability of essential medicines for children is 1.6%–46.5%. The availability of generics was generally higher than original brands in public hospitals and the prices of generics were relatively lower and more ...
Chen Z, Li S, Choonara I, Zou K, Zeng L, Huang L, Jia ZJ, Cheng G, Jiang Y, Tang Y, Zhao S, Zhang L.   +11 more
europepmc   +4 more sources

Facebook as a source of access to medicines. [PDF]

PLoS One, 2022
Over the last decade, we’ve observed an enormous social media development, which have recently become commercial services. Hence, we aimed to verify if Facebook might be considered as a source of access to medicines. We also intended to identify prescription (Rx) and over the counter (OTC) medicines if available on that platform.
Zaprutko T, Kopciuch D, Paczkowska A, Sprawka J, Cynar J, Pogodzińska M, Niewczas K, Stolecka A, Sygit M, Michalak M, Ratajczak P, Kus K.   +11 more
europepmc   +5 more sources

Access to Essential Cardiovascular Medicines in Pakistan: A National Survey on the Availability, Price, and Affordability, Using WHO/HAI Methodology

Frontiers in Pharmacology, 2021
Objective: This national survey was aimed at measuring the access to cardiovascular disease (CVD) medicines in terms of their availability, price, and affordability in Pakistan.
Amna Saeed, Amna Saeed, Amna Saeed, Amna Saeed, Faria Saeed, Hamid Saeed, Zikria Saleem, Caijun Yang, Caijun Yang, Caijun Yang, Jie Chang, Jie Chang, Jie Chang, Minghuan Jiang, Minghuan Jiang, Minghuan Jiang, Mingyue Zhao, Mingyue Zhao, Mingyue Zhao, Muhammad Saqlain, Wenjing Ji, Wenjing Ji, Wenjing Ji, Muhammad Majid Aziz, Muhammad Majid Aziz, Muhammad Majid Aziz, Krizzia Lambojon, Krizzia Lambojon, Krizzia Lambojon, Ali Hassan Gillani, Ali Hassan Gillani, Ali Hassan Gillani, Khezar Hayat, Khezar Hayat, Khezar Hayat, Khezar Hayat, Sabiha Gul, Yu Fang, Yu Fang, Yu Fang, Zaheer-Ud-Din Babar   +40 more
doaj   +3 more sources

Molecular farming, patents and access to medicines

Expert Review of Vaccines, 2010
Transgenic plants have several advantages over other expression systems for the production of recombinant medicines, including low costs, large-scale production and the ability to produce complex multimeric proteins with appropriate post-translational modifications.
Drake, Pascal MW, Thangaraj, Harry
exaly   +3 more sources

Deepening Accountability: The Fair Pharma Scorecard and Access to Medicines in a Fragmented Global Health Law Landscape [PDF]

Health and Human Rights
The international legal landscape governing global health is characterized by regime complexity and legal fragmentation, with overlapping and sometimes conflicting legal norms.
Rosalind Turkie, Pramiti Parwani
doaj   +1 more source

Access to medicines. [PDF]

Eur J Hosp Pharm, 2023
Miljković N, Makridaki D, Kohl S.
europepmc   +3 more sources

Access to hepatitis C medicines

Bulletin of the World Health Organization, 2015
Hepatitis C is a global epidemic. Worldwide, 185 million people are estimated to be infected, most of whom live in low- and middle-income countries. Recent advances in the development of antiviral drugs have produced therapies that are more effective ...
Danny J Edwards, Delphi GM Coppens, Tara L Prasad, Laurien A Rook, Jayasree K Iyer   +4 more
doaj   +3 more sources

HIV supply chains in low- and middle-income countries: overview and research opportunities [PDF]

Journal of Humanitarian Logistics and Supply Chain Management, 2021
Purpose – Despite HIV being reported as one of the major global health issues, availability and accessibility of HIV services and supplies remain limited, especially in low- and middle-income countries. The effective and efficient operation of HIV supply
Sofie Stulens, Kim De Boeck, Nico Vandaele   +2 more
doaj   +1 more source

Modeling Supply and Demand Dynamics of Vaccines against Epidemic-Prone Pathogens: Case Study of Ebola Virus Disease

Vaccines, 2023
Health emergencies caused by epidemic-prone pathogens (EPPs) have increased exponentially in recent decades. Although vaccines have proven beneficial, they are unavailable for many pathogens. Furthermore, achieving timely and equitable access to vaccines
Donovan Guttieres, Charlot Diepvens, Catherine Decouttere, Nico Vandaele   +3 more
doaj   +1 more source